232 related articles for article (PubMed ID: 32641979)
1. Mass spectrometry imaging-based metabolomics to visualize the spatially resolved reprogramming of carnitine metabolism in breast cancer.
Sun C; Wang F; Zhang Y; Yu J; Wang X
Theranostics; 2020; 10(16):7070-7082. PubMed ID: 32641979
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2.
Lu X; Zhang X; Zhang Y; Zhang K; Zhan C; Shi X; Li Y; Zhao J; Bai Y; Wang Y; Nie H; Li Y
Mol Carcinog; 2019 May; 58(5):749-759. PubMed ID: 30604893
[TBL] [Abstract][Full Text] [Related]
3. Tandem mass spectrometric assay for the determination of carnitine palmitoyltransferase II activity in muscle tissue.
Rettinger A; Gempel K; Hofmann S; Gerbitz KD; Bauer MF
Anal Biochem; 2002 Mar; 302(2):246-51. PubMed ID: 11878804
[TBL] [Abstract][Full Text] [Related]
4. Obesity and lipid stress inhibit carnitine acetyltransferase activity.
Seiler SE; Martin OJ; Noland RC; Slentz DH; DeBalsi KL; Ilkayeva OR; An J; Newgard CB; Koves TR; Muoio DM
J Lipid Res; 2014 Apr; 55(4):635-44. PubMed ID: 24395925
[TBL] [Abstract][Full Text] [Related]
5. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism.
Violante S; Ijlst L; Ruiter J; Koster J; van Lenthe H; Duran M; de Almeida IT; Wanders RJ; Houten SM; Ventura FV
Biochim Biophys Acta; 2013 Jun; 1832(6):773-9. PubMed ID: 23485643
[TBL] [Abstract][Full Text] [Related]
6. Spatially resolved metabolomics to discover tumor-associated metabolic alterations.
Sun C; Li T; Song X; Huang L; Zang Q; Xu J; Bi N; Jiao G; Hao Y; Chen Y; Zhang R; Luo Z; Li X; Wang L; Wang Z; Song Y; He J; Abliz Z
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):52-57. PubMed ID: 30559182
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic studies of breast cancer in murine models: A review.
Araújo R; Bispo D; Helguero LA; Gil AM
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165713. PubMed ID: 32014550
[TBL] [Abstract][Full Text] [Related]
8. Urinary metabolomic study of non-small cell lung carcinoma based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Wu Q; Wang Y; Gu X; Zhou J; Zhang H; Lv W; Chen Z; Yan C
J Sep Sci; 2014 Jul; 37(14):1728-35. PubMed ID: 24771673
[TBL] [Abstract][Full Text] [Related]
9. Orange juice affects acylcarnitine metabolism in healthy volunteers as revealed by a mass-spectrometry based metabolomics approach.
Moreira V; Brasili E; Fiamoncini J; Marini F; Miccheli A; Daniel H; Lee JJH; Hassimotto NMA; Lajolo FM
Food Res Int; 2018 May; 107():346-352. PubMed ID: 29580494
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models.
Chughtai K; Jiang L; Greenwood TR; Glunde K; Heeren RM
J Lipid Res; 2013 Feb; 54(2):333-44. PubMed ID: 22930811
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic analysis reveals that carnitines are key regulatory metabolites in phase transition of the locusts.
Wu R; Wu Z; Wang X; Yang P; Yu D; Zhao C; Xu G; Kang L
Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3259-63. PubMed ID: 22328148
[TBL] [Abstract][Full Text] [Related]
12. Differences between acylcarnitine profiles in plasma and bloodspots.
de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
[TBL] [Abstract][Full Text] [Related]
13. Carnitine palmitoyltransferase 1C contributes to progressive cellular senescence.
Wang Y; Yu T; Zhou Y; Wang S; Zhou X; Wang L; Ou T; Chen Y; Zhou Y; Zhang H; Wang Y; Fan X; Chen P; Gonzalez FJ; Yu A; Huang P; Huang M; Bi H
Aging (Albany NY); 2020 Apr; 12(8):6733-6755. PubMed ID: 32289751
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis.
Chen C; Hou G; Zeng C; Ren Y; Chen X; Peng C
Theranostics; 2021; 11(2):754-767. PubMed ID: 33391503
[TBL] [Abstract][Full Text] [Related]
15. The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach.
Das M; Giannoudis A; Sharma V
Sci Rep; 2022 Sep; 12(1):16441. PubMed ID: 36180554
[TBL] [Abstract][Full Text] [Related]
16. Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry.
Gempel K; Kiechl S; Hofmann S; Lochmüller H; Kiechl-Kohlendorfer U; Willeit J; Sperl W; Rettinger A; Bieger I; Pongratz D; Gerbitz KD; Bauer MF
J Inherit Metab Dis; 2002 Feb; 25(1):17-27. PubMed ID: 11999976
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic profiles of 38 acylcarnitines in major depressive episodes before and after treatment.
Ait Tayeb AEK; Colle R; Chappell K; El-Asmar K; Acquaviva-Bourdain C; David DJ; Trabado S; Chanson P; Feve B; Becquemont L; Verstuyft C; Corruble E
Psychol Med; 2024 Jan; 54(2):289-298. PubMed ID: 37226550
[TBL] [Abstract][Full Text] [Related]
18. Integrated spatially resolved metabolomics and network toxicology to investigate the hepatotoxicity mechanisms of component D of Polygonum multiflorum Thunb.
Jiang HY; Gao HY; Li J; Zhou TY; Wang ST; Yang JB; Hao RR; Pang F; Wei F; Liu ZG; Kuang L; Ma SC; He JM; Jin HT
J Ethnopharmacol; 2022 Nov; 298():115630. PubMed ID: 35987407
[TBL] [Abstract][Full Text] [Related]
19. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling.
Violante S; Ijlst L; van Lenthe H; de Almeida IT; Wanders RJ; Ventura FV
Biochim Biophys Acta; 2010 Sep; 1802(9):728-32. PubMed ID: 20538056
[TBL] [Abstract][Full Text] [Related]
20. Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
Tan Z; Zou Y; Zhu M; Luo Z; Wu T; Zheng C; Xie A; Wang H; Fang S; Liu S; Li Y; Lu Z
BMC Cancer; 2021 Apr; 21(1):409. PubMed ID: 33858374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
